Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis

Arthritis and Rheumatology

Volumn 66, Issue 4, 2014, Pages 841-851

  Fert, Ingrid ^a   Cagnard, Nicolas ^a   Glatigny, Simon ^a   Letourneur, Franck ^a   Jacques, Sébastien ^a   Smith, Judith A ^b   Colbert, Robert A ^c   Taurog, Joel D ^d   Chiocchia, Gilles ^a   Araujo, Luiza M ^a   Breban, Maxime ^a,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 27; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONDYLARTHRITIS; UPREGULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; GENE EXPRESSION PROFILING; HLA-B27 ANTIGEN; HUMANS; INTERFERON-GAMMA; MACROPHAGES; RATS; RATS, TRANSGENIC; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTES, REGULATORY;

EID: 84898627352     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38318     Document Type: Article

References (44)

1. Van Tubergen A, Weber U,. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol 2012; 8: 253-61.
2. Taurog JD,. The role of HLA-B27 in spondyloarthritis. J Rheumatol 2010; 37: 2606-16.
3. McHugh K, Bowness P,. The link between HLA-B27 and SpA-new ideas on an old problem. Rheumatology (Oxford) 2012; 51: 1529-39.
4. Hacquard-Bouder C, Falgarone G, Bosquet A, Smaoui F, Monnet D, Ittah M, et al. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy. Arthritis Rheum 2004; 50: 1624-35.
5. Breban M, Hacquard-Bouder C, Falgarone G,. Animal models of HLA-B27-associated diseases. Curr Mol Med 2004; 4: 31-40.
6. Breban M, Hammer RE, Richardson JA, Taurog JD,. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 1993; 178: 1607-16.
7. Breban M, Fernandez-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996; 156: 794-803.
8. Hacquard-Bouder C, Chimenti MS, Giquel B, Donnadieu E, Fert I, Schmitt A, et al. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum 2007; 56: 1478-89.
9. Dhaenens M, Fert I, Glatigny S, Haerinck S, Poulain C, Donnadieu E, et al. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability. Arthritis Rheum 2009; 60: 2622-32.
10. Utriainen L, Firmin D, Wright P, Cerovic V, Breban M, McInnes I, et al. Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis. Arthritis Rheum 2012; 64: 3199-209.
11. 2-microglobulin-transgenic rat lines. Arthritis Rheum 2008; 58: 3425-9.
12. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA,. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60: 2633-43.
13. Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, et al. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum 2012; 64: 110-20.
14. Krause L, Fert I, Labroquere K, Andrieu M, Chiocchia G, Breban MA,. Regulatory T cells in spondyloarthritis (SpA) animal model and modulatory role of inducible costimulator (ICOS) [abstract]. Arthritis Rheum 2012; 64 Suppl: S260-1.
15. Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA,. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-γ dysregulation. Arthritis Rheum 2008; 58: 1640-9.
16. Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999; 169: 209-23.
17. 2+-dependent mechanism. J Exp Med 1997; 186: 467-72.
18. dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33: 375-86.
19. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, et al. MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 2010; 11: 74.
20. Pohjanvirta R, Niittynen M, Linden J, Boutros PC, Moffat ID, Okey AB,. Evaluation of various housekeeping genes for their applicability for normalization of mRNA expression in dioxin-treated rats. Chem Biol Interact 2006; 160: 134-49.
21. Murugaiyan G, Mittal A, Weiner HL,. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-γ limits IL-17-mediated autoimmune inflammation. Proc Natl Acad Sci U S A 2010; 107: 11495-500.
22. Colbert RA, DeLay ML, Klenk EI, Layh-Schmitt G,. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev 2010; 233: 181-202.
23. Benjamin R, Parham P,. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137-42.
24. May E, Dorris ML, Satumtira N, Iqbal I, Rehman MI, Lightfoot E, et al. CD8αβ T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003; 170: 1099-105.
25. 2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum 2009; 60: 1977-84.
26. 2-microglobulin- transgenic rat model of spondylarthritis. Arthritis Rheum 2012; 64: 3210-9.
27. - entheseal resident T cells. Nat Med 2012; 18: 1069-76.
28. Bonilla N, Breban M, Chiocchia G,. Heightened HLA molecules upregulation and decreased CD4+ T cells stimulation in monocytes-derived dendritic cells (DCs) from ankylosing spondylitis (AS) patients [abstract]. Arthritis Rheum 2009; 60 Suppl: S535-6.
29. Voisine C, Hubert FX, Trinite B, Heslan M, Josien R,. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J Immunol 2002; 169: 2284-91.
30. Baeten D, Breban M, Lories R, Schett G, Sieper J,. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? [review]. Arthritis Rheum 2013; 65: 12-20.
31. + T cells in an interleukin-10-dependent manner. Immunity 2011; 34: 554-65.
32. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011; 34: 566-78.
33. Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, et al. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis. Rheumatology (Oxford) 2008; 47: 1775-9.
34. Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Multiple novel loci harboring common and rare variants implicated in ankylosing spondylitis. Nature Genet 2013; 45: 730-8.
35. MacMicking JD,. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 2012; 12: 367-82.
36. Warner TF, Madsen J, Starling J, Wagner RD, Taurog JD, Balish E,. Human HLA-B27 gene enhances susceptibility of rats to oral infection by Listeria monocytogenes. Am J Pathol 1996; 149: 1737-43.
37. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD,. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 1998; 66: 6022-3.
38. Bach MH, Van Gelder RN, Taurog JD, Rosenbaum JT,. The presence of HLA-B27 shapes gut microbiome composition in rats [abstract]. Arthritis Rheum 2012; 64 Suppl: S1052-3.
39. Yoshimura A, Naka T, Kubo M,. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7: 454-65.
40. Lemke G, Rothlin CV,. Immunobiology of the TAM receptors. Nat Rev Immunol 2008; 8: 327-36.
41. Gur H, El-Zaatari F, Geppert TD, Wacholtz MC, Taurog JD, Lipsky PE,. Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction. J Exp Med 1990; 172: 1267-70.
42. Jin YP, Korin Y, Zhang X, Jindra PT, Rozengurt E, Reed EF,. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol 2007; 178: 7911-22.
43. Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173: 1699-710.
44. Xu S, Liu X, Bao Y, Zhu X, Han C, Zhang P, et al. Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat Immunol 2012; 13: 551-9.